Molly Harper, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 17,500 shares at $22.00 ($385K) on 2024-11-27, disclosed to the SEC on 2024-11-29.
Open-market sale of $385k CPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CPRX | SELL | 2023-12-19 | $201K | — | Filing → |